MEI Pharma, Inc.

NasdaqCM:MEIP Rapporto sulle azioni

Cap. di mercato: US$18.7m

MEI Pharma Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jay File

Amministratore delegato

US$655.7k

Compenso totale

Percentuale dello stipendio del CEO68.6%
Mandato del CEO1.3yrs
Proprietà del CEOn/a
Durata media del management2.1yrs
Durata media del Consiglio di amministrazione3.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Dec 30
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

Nov 19
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Mar 26
Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

Feb 12
Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

MEI Pharma: Another PI3K Delta Progressing To The FDA

Feb 01

Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

Dec 02
Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

MEI Pharma EPS misses by $0.12, misses on revenue

May 06

MEI Pharma promotes Richard Ghalie to chief medical officer

Apr 30

MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued

Apr 26

The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

Feb 25
The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 11
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jay File rispetto agli utili di MEI Pharma?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$47m

Jun 30 2024US$656kUS$450k

US$18m

Compensazione vs Mercato: La retribuzione totale di Jay ($USD 655.65K ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 650.80K ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Jay con le performance aziendali.


AMMINISTRATORE DELEGATO

Jay File (54 yo)

1.3yrs

Mandato

US$655,650

Compensazione

Mr. Justin J. File, also known as Jay, serves as CFO & Corporate Secretary at MEI Pharma, Inc. since August 01, 2023 and serves as its Acting Chief Executive Officer from August 01, 2024. He had been an Ex...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Justin File
Acting CEO1.3yrsUS$655.65kNessun dato
Yomara Gomez-Naiden
Senior Vice President of Operations & Quality1.3yrsNessun datoNessun dato
Nicole Iida
Vice President of Legal Affairs1.8yrsNessun datoNessun dato
Anne Frese
Chief People Officer2.4yrsNessun datoNessun dato
Robert Mass
Strategic Advisor13.4yrsUS$755.98kNessun dato
David Walsey
Senior Vice President of Corporate Affairs3.5yrsNessun datoNessun dato

2.1yrs

Durata media

Gestione esperta: Il team dirigenziale di MEIP è considerato esperto (durata media dell'incarico 2.1 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Frederick Driscoll
Independent Chairperson6.8yrsUS$117.20k0.028%
$ 5.3k
Nicholas Glover
Independent Non-Executive Director11.4yrsUS$122.78k0%
$ 0
Thomas Reynolds
Independent Non-Executive Director11.8yrsUS$115.28k0.0075%
$ 1.4k
Steven Wood
Independent Non-Executive Director1.1yrsUS$112.40k0.14%
$ 26.3k
James Flynn
Independent Directorless than a yearUS$114.07k0.12%
$ 22.2k
Taheer Datoo
Directorless than a yearUS$68.06kNessun dato

3.9yrs

Durata media

49yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MEIP sono considerati esperti (durata media dell'incarico 3.9 anni).